The use of gastroepiploic artery for coronary artery bypass surgery

Sujit Banyatpiyaphod1, Kitipan Visudharom, Vibul Jotisakulratana

  • 1Bangkok Heart Institute, Bangkok Hospital, Bangkok 10320, Thailand.

Insights

The right gastroepiploic artery (GEA) offers a promising alternative arterial conduit for coronary artery bypass surgery, demonstrating better long-term patency compared to traditional vein grafts. This review highlights its growing popularity and effectiveness in all-arterial bypass procedures.

Area of Science:

  • Cardiovascular Surgery
  • Vascular Biology
  • Surgical Innovation

Background:

  • Coronary heart disease necessitates bypass surgery, often using grafts.
  • Saphenous vein grafts have a high occlusion rate (over 50% at 10 years).
  • Arterial conduits like internal mammary and radial arteries are established alternatives.

Purpose of the Study:

  • To review current literature on the right gastroepiploic artery (GEA) as a coronary bypass conduit.
  • To present institutional experience with GEA utilization.
  • To evaluate GEA's potential for improved long-term graft patency.

Main Methods:

  • Literature review of recent reports on GEA in coronary bypass.
  • Analysis of institutional surgical case data involving GEA.
  • Comparison of GEA outcomes with other arterial and venous conduits.

Main Results:

  • The right gastroepiploic artery (GEA) is increasingly favored by cardiac surgeons.
  • GEA can be combined with other arterial grafts for 'all-arterial' bypass.
  • GEA shows potential for superior long-term patency rates.

Conclusions:

  • The right gastroepiploic artery (GEA) is a viable and effective arterial conduit for coronary artery bypass grafting.
  • All-arterial bypass surgery utilizing GEA may offer enhanced long-term graft patency.
  • GEA represents a valuable option in the surgical treatment of coronary heart disease.

Related Concept Videos